by Brad N. Taylor, Ph.D. | Mar 7, 2023
San Diego, CA, March 7, 2023 – In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a...
by Brad N. Taylor, Ph.D. | Sep 23, 2022
(San Diego, CA – September 23, 2022) — Nucleus Biologics, The Cell Performance Company™, an industry-leading provider of small lot custom cell culture media, celebrated the opening of its newest building on their San Diego campus and the unveiling of additional...
by Brad N. Taylor, Ph.D. | Aug 23, 2022
ISO 13485:2016 certification demonstrates Nucleus Biologics’ commitment to maintaining premium quality standards. (San Diego, CA – August 23, 2022) Nucleus Biologics, The Cell Performance Company™, the industry-leading provider of small lot custom media for the cell...
by Brad N. Taylor, Ph.D. | Feb 28, 2022
Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...
by Brad N. Taylor, Ph.D. | Jan 20, 2022
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and...
